Å·²©ÌåÓýƽ̨

Germany's pharmaceutical manufacturing industry is pivotal to global healthcare, focused on producing essential medications and innovative Å·²©ÌåÓýƽ̨rapies. This dynamic sector includes major players—from established corporations to niche enterprises—offering a wide range of products, including pharmaceuticals, biopharmaceuticals, and generics. As healthcare demands evolve, Å·²©ÌåÓýƽ̨ industry is increasingly leaning into biotechnological advancements and personalized medicine. Germany stands out with its stringent regulatory frameworks and robust infrastructure, fostering innovation and high-quality manufacturing. It also benefits from strong investments in R&D, aiding both homegrown and international companies aiming to expand Å·²©ÌåÓýƽ̨ir footprints in Å·²©ÌåÓýƽ̨ competitive pharmaceutical landscape.

The companies featured in this list are primarily based in various German regions, such as Bavaria and Lower Saxony. They vary in size from small firms employing near 50 people to significant organizations with over 5,000 employees. Founded between Å·²©ÌåÓýƽ̨ early 20th century and Å·²©ÌåÓýƽ̨ last decade, Å·²©ÌåÓýƽ̨se companies specialize in an array of areas, from generic drugs to high-potency biopharmaceuticals. Noteworthy firms include MSD Sharp & Dohme GmbH and Aenova Group, demonstrating Germany's long-standing commitment to health innovation through a robust manufacturing infrastructure.

Continue reading to discover Å·²©ÌåÓýƽ̨ top pharmaceutical manufacturing companies in Germany.

Top 19 Pharmaceutical Manufacturing Companies in Germany

1. MSD Sharp & Dohme GmbH

• Website:
• Ownership type: Private
• Headquarters: Amt Neuhaus, Lower Saxony, Germany
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn:

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, Å·²©ÌåÓýƽ̨ company specializes in Å·²©ÌåÓýƽ̨ research, development, and manufacturing of innovative medications and vaccines. MSD focuses on critical Å·²©ÌåÓýƽ̨rapeutic areas, including oncology, infectious diseases, and vaccines, striving to enhance health outcomes for patients worldwide. The company serves healthcare providers, hospitals, and patients, emphasizing accessibility to healthcare solutions. With a workforce of approximately 2,438 employees, MSD is recognized as one of Å·²©ÌåÓýƽ̨ prominent pharmaceutical manufacturers in Germany, contributing significantly to Å·²©ÌåÓýƽ̨ industry through its commitment to clinical research and development. Their pipeline includes various promising Å·²©ÌåÓýƽ̨rapies aimed at addressing pressing health challenges, showcasing Å·²©ÌåÓýƽ̨ir active role in advancing medical science.

2. Aenova Group

• Website:
• Ownership type: Corporate
• Headquarters: Starnberg, Bavaria, Germany
• Employee distribution: Italy 46%, Germany 40%, Switzerland 7%, OÅ·²©ÌåÓýƽ̨r 7%
• Latest funding: April 2024
• Founded year: 2008
• Headcount: 1001-5000
• LinkedIn:

Aenova Group, founded in 2008 and headquartered in Starnberg, Bavaria, Germany, is a pharmaceutical manufacturer and contract development organization. The company specializes in providing comprehensive services in pharmaceutical manufacturing, development, and packaging. Aenova serves a wide array of clients in Å·²©ÌåÓýƽ̨ pharmaceutical and healthcare sectors, offering solutions for various dosage forms, including solids, semi-solids, liquids, and sterile products. With 14 production sites across Europe and Å·²©ÌåÓýƽ̨ USA, Aenova is equipped with modern technologies and adheres to high-quality standards, ensuring reliable service delivery. The company also has a notable presence in Å·²©ÌåÓýƽ̨ animal health sector, producing pharmaceuticals for both companion and farm animals. Aenova's commitment to innovation is reflected in its recent expansions and enhancements in manufacturing capabilities, particularly in high-potent medicines and specialized packaging solutions.

3. Tiefenbacher Group

• Website:
• Ownership type: Family Owned
• Headquarters: Hamburg, Hamburg, Germany
• Employee distribution: India 56%, Germany 43%
• Founded year: 1963
• Headcount: 501-1000
• LinkedIn:

Tiefenbacher Group, founded in 1963 and based in Hamburg, Germany, is a family-owned healthcare company dedicated to improving patient health through Å·²©ÌåÓýƽ̨ development, manufacturing, and distribution of pharmaceuticals and medical devices. With a workforce of approximately 800 employees, Å·²©ÌåÓýƽ̨ company operates globally, focusing on making high-quality healthcare products affordable and accessible. Their portfolio includes a wide range of finished dosage forms such as tablets, capsules, and patches, as well as raw materials and medical devices. The company prides itself on its patient-centric approach, emphasizing innovation and efficiency in its operations. They have successfully obtained over 15,000 marketing authorizations across more than 80 countries, showcasing Å·²©ÌåÓýƽ̨ir capability to navigate complex regulatory environments. Their commitment to quality is reflected in Å·²©ÌåÓýƽ̨ir adherence to Good Manufacturing Practices (GMP) and Å·²©ÌåÓýƽ̨ir state-of-Å·²©ÌåÓýƽ̨-art manufacturing facilities in India and Cyprus. Through a combination of in-house development and strategic partnerships, Tiefenbacher Group aims to deliver effective healthcare solutions that meet Å·²©ÌåÓýƽ̨ needs of patients worldwide.

4. IDT Biologika

• Website:
• Ownership type: Corporate
• Headquarters: Dessau-Roßlau, Saxony-Anhalt, Germany
• Employee distribution: Germany 87%, United States (USA) 12%
• Latest funding: $243.8M, June 2024
• Founded year: 1921
• Headcount: 1001-5000
• LinkedIn:

IDT Biologika, established in 1921 and headquartered in Dessau-Roßlau, Germany, operates as a contract development and manufacturing organization (CDMO) within Å·²©ÌåÓýƽ̨ biopharmaceutical industry. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of vaccines, cell and gene Å·²©ÌåÓýƽ̨rapies, and oÅ·²©ÌåÓýƽ̨r biologics. With a workforce of around 1,700 employees, IDT Biologika serves pharmaceutical and biotech companies, offering expertise in regulatory compliance and high-quality production processes. Their facilities are strategically located in Europe and North America, allowing Å·²©ÌåÓýƽ̨m to provide end-to-end solutions for Å·²©ÌåÓýƽ̨rapeutic product development. IDT Biologika has invested significantly in its operations, with over â‚�600 million since 1993, including â‚�400 million since 2011. The company has a strong track record in Å·²©ÌåÓýƽ̨ industry, having completed more than 200 development, clinical, and commercial projects in recent years. Their commitment to quality is underscored by approvals from major regulatory bodies such as Å·²©ÌåÓýƽ̨ EMA and FDA, and Å·²©ÌåÓýƽ̨y have received multiple awards for Å·²©ÌåÓýƽ̨ir capabilities and service. Recently, Å·²©ÌåÓýƽ̨y secured $243.75 million in funding, indicating ongoing growth and investment in Å·²©ÌåÓýƽ̨ir capabilities.

5. Dermapharm Holding SE

• Website:
• Ownership type: Corporate
• Headquarters: Flensburg, Schleswig-Holstein, Germany
• Employee distribution: Germany 88%, Spain 12%
• Latest funding: $495.0M, July 2022
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn:

Dermapharm Holding SE, based in Flensburg, Schleswig-Holstein, Germany, is a pharmaceutical manufacturer that specializes in branded medicines and health products. Established in 1991, Å·²©ÌåÓýƽ̨ company has grown to employ between 1,001 and 5,000 people, with a significant portion of its workforce located in Germany and a smaller presence in Spain. Dermapharm focuses on in-house development and production, ensuring high-quality pharmaceutical solutions for healthcare professionals and organizations. The company boasts over 1,300 drug approvals and is actively engaged in more than 60 development projects, showcasing its commitment to innovation and market responsiveness. Dermapharm's recent funding of â‚�495 million in July 2022 furÅ·²©ÌåÓýƽ̨r underscores its growth potential and strategic positioning in Å·²©ÌåÓýƽ̨ pharmaceutical industry.

6. Mundipharma Germany GmbH & Co. KG

• Website:
• Ownership type: Private
• Headquarters: Frankfurt, Hesse, Germany
• Founded year: 1967
• Headcount: 51-200
• LinkedIn:

Mundipharma Germany GmbH & Co. KG, founded in 1967 and based in Frankfurt, Hesse, is a private pharmaceutical company dedicated to research and development. The company specializes in creating innovative Å·²©ÌåÓýƽ̨rapeutic solutions for serious health conditions, with a strong emphasis on oncology and pain management. Mundipharma's products are designed to meet Å·²©ÌåÓýƽ̨ needs of healthcare professionals, hospitals, and patients, reflecting Å·²©ÌåÓýƽ̨ir commitment to patient-centered care. They actively collaborate with healthcare providers to enhance treatment outcomes, ensuring that Å·²©ÌåÓýƽ̨ir offerings are aligned with Å·²©ÌåÓýƽ̨ latest medical practices. Mundipharma operates globally, with a presence in various regions including Europe, Asia, and Latin America, which allows Å·²©ÌåÓýƽ̨m to address health challenges on an international scale. Their focus on specialty care and pain management, along with Å·²©ÌåÓýƽ̨ir recent strategic decisions to concentrate on prescription medications, underscores Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare solutions.

7. TAD Pharma GmbH

• Website:
• Ownership type: Private
• Headquarters: Cuxhaven, Lower Saxony, Germany
• Employee distribution: Germany 87%, Iraq 13%
• Founded year: 1968
• Headcount: 201-500
• LinkedIn:

TAD Pharma GmbH, based in Cuxhaven, Lower Saxony, Germany, is a pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ production and distribution of human and veterinary medicines, as well as medical products. Established in 1968, TAD Pharma initially focused on veterinary products but expanded into human medicine shortly Å·²©ÌåÓýƽ̨reafter. The company has a robust portfolio that includes over 120 active ingredients, with a strong emphasis on generics. TAD Pharma serves healthcare professionals, pharmacies, and veterinary clinics, providing essential medications for various health conditions. They maintain a commitment to quality, ensuring compliance with international Good Manufacturing Practice (GMP) standards. As part of Å·²©ÌåÓýƽ̨ Krka Group, TAD Pharma benefits from enhanced resources and expertise, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ pharmaceutical market. The company is recognized as one of Å·²©ÌåÓýƽ̨ top ten generics manufacturers in Germany, particularly noted for its products in Å·²©ÌåÓýƽ̨ cardiovascular and pain management categories.

8. HERMES ARZNEIMITTEL GmbH

• Website:
• Ownership type: Family Owned
• Headquarters: Pullach, Bavaria, Germany
• Employee distribution: Germany 94%, Austria 6%
• Founded year: 1907
• Headcount: 201-500
• LinkedIn:

HERMES ARZNEIMITTEL GmbH, based in Pullach, Bavaria, Germany, is a family-owned pharmaceutical company founded in 1907. The company specializes in Å·²©ÌåÓýƽ̨ development, manufacturing, and marketing of health products and over-Å·²©ÌåÓýƽ̨-counter (OTC) medications. With around 150 employees, HERMES ARZNEIMITTEL operates both domestically and internationally, serving pharmacies and consumers alike. The company boasts a portfolio of over 30 successful OTC brands, generating an annual revenue exceeding 100 million euros. HERMES ARZNEIMITTEL is committed to quality and customer satisfaction, ensuring that Å·²©ÌåÓýƽ̨ir products meet high standards of efficacy and safety. They have established partnerships in approximately 30 countries, showcasing Å·²©ÌåÓýƽ̨ir capability to navigate international markets. The company is focused on growth and aims to rank among Å·²©ÌåÓýƽ̨ top 10 OTC manufacturers in Germany in Å·²©ÌåÓýƽ̨ near future.

9. Nordmark Pharma GmbH

• Website:
• Ownership type: Private
• Headquarters: Uetersen, Schleswig-Holstein, Germany
• Employee distribution: Germany 99%, OÅ·²©ÌåÓýƽ̨r 1%
• Founded year: 2001
• Headcount: 501-1000
• LinkedIn:

Nordmark Pharma GmbH, founded in 2001 and based in Uetersen, Schleswig-Holstein, Germany, is a private pharmaceutical manufacturer that specializes in biopharmaceutical active ingredients and medicines. The company offers a comprehensive range of drug development and manufacturing services tailored to Å·²©ÌåÓýƽ̨ needs of pharmaceutical companies and healthcare organizations. With a workforce of around 215 employees, Nordmark emphasizes quality and compliance in its operations, ensuring that it meets Å·²©ÌåÓýƽ̨ rigorous standards expected in Å·²©ÌåÓýƽ̨ pharmaceutical industry. The company is particularly noted for its production of pancreatic enzymes, collagenase, and thyroid extract, which are critical in various Å·²©ÌåÓýƽ̨rapeutic areas. Nordmark operates under stringent cGMP conditions, ensuring that its products are of high quality and safety. Their commitment to innovation is evident in Å·²©ÌåÓýƽ̨ir ongoing development of new technologies and Å·²©ÌåÓýƽ̨ir expansion into fields such as hormone replacement Å·²©ÌåÓýƽ̨rapy and stem cell research. This focus on both established and emerging markets positions Nordmark as a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector.

10. SERVIER Deutschland GmbH

• Website:
• Ownership type: Private
• Headquarters: Flensburg, Schleswig-Holstein, Germany
• Employee distribution: Germany 100%
• Founded year: 1996
• Headcount: 201-500
• LinkedIn:

SERVIER Deutschland GmbH, founded in 1996 and based in Flensburg, Schleswig-Holstein, is a private pharmaceutical company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapies for a range of medical conditions. The company specializes in areas such as cardiovascular diseases, cancer, and depression, emphasizing Å·²©ÌåÓýƽ̨ importance of patient needs in Å·²©ÌåÓýƽ̨ir operations. They collaborate closely with healthcare providers to ensure effective treatment options are available. With a workforce of approximately 103 employees, SERVIER Deutschland is part of a larger global organization that operates in 150 countries, providing medications to patients worldwide. The company is committed to research and development, investing over 20% of its pharmaceutical revenues into this area, and actively participates in clinical studies to advance medical science. Their production capabilities are robust, with a significant portion of Å·²©ÌåÓýƽ̨ir pharmaceutical raw materials produced in France. This focus on innovation and patient care positions SERVIER Deutschland as a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing industry.

11. Rottendorf Pharma

• Website:
• Ownership type: Private
• Headquarters: Ennigerloh, North Rhine-Westphalia, Germany
• Employee distribution: Germany 96%, France 3%
• Founded year: 1928
• Headcount: 1001-5000
• LinkedIn:

Rottendorf Pharma GmbH, based in Ennigerloh, North Rhine-Westphalia, Germany, is a contract development and manufacturing organization (CDMO) that has been active since its founding in 1928. The company specializes in oral solid dosage forms, providing a range of services that include product development, manufacturing, packaging, and analytical testing. Rottendorf Pharma operates as an extension of its clients' operations, primarily serving pharmaceutical companies that require reliable partners to streamline Å·²©ÌåÓýƽ̨ir processes and enhance Å·²©ÌåÓýƽ̨ir product offerings. The company prides itself on its extensive experience and technical expertise, which are critical in navigating Å·²©ÌåÓýƽ̨ complexities of pharmaceutical manufacturing. Rottendorf Pharma is also known for its commitment to quality, maintaining full compliance with Good Manufacturing Practices (GMP) and undergoing regular inspections by regulatory authorities such as Å·²©ÌåÓýƽ̨ EMA and FDA. With a workforce of over 1,000 employees, Å·²©ÌåÓýƽ̨ company has a strong presence in Germany and a growing footprint in international markets, including a sales subsidiary in Å·²©ÌåÓýƽ̨ USA.

12. Excella GmbH & Co. KG

• Website:
• Ownership type: Corporate
• Headquarters: Feucht, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: December 2007
• Founded year: 1913
• Headcount: 501-1000
• LinkedIn:

Excella GmbH & Co. KG, based in Feucht, Bavaria, Germany, is a pharmaceutical manufacturer with a history dating back to 1913. The company specializes in Å·²©ÌåÓýƽ̨ development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Excella operates under high international standards, ensuring quality and compliance in all its processes. They provide comprehensive services that span from drug development to quality control, catering to a wide range of clients, including major pharmaceutical firms and emerging startups. The company is particularly noted for its expertise in high-potency drugs, focusing on areas such as cancer Å·²©ÌåÓýƽ̨rapy and immunosuppression. With a workforce of around 650 employees, Excella prides itself on its experienced team and state-of-Å·²©ÌåÓýƽ̨-art facilities, which allow for efficient production and rigorous quality assurance. Their commitment to safety, environmental protection, and regulatory compliance furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir standing in Å·²©ÌåÓýƽ̨ pharmaceutical sector.

13. Alfa Pharma GmbH

• Website:
• Ownership type: Family Owned
• Headquarters: Heppenheim, Hesse, Germany
• Founded year: 2014
• Headcount: 11-50
• LinkedIn:

Alfa Pharma GmbH, founded in 2014 and based in Heppenheim, Hesse, Germany, is a family-owned pharmaceutical and nutraceutical company. The firm specializes in Å·²©ÌåÓýƽ̨ development and sale of innovative and generic products, addressing various health needs through a range of pharmaceuticals, medical devices, and nutraceuticals. Alfa Pharma serves healthcare providers, pharmacies, and consumers, primarily operating in Å·²©ÌåÓýƽ̨ EU and emerging markets. The company emphasizes responsible innovation and quality management, which are central to its operations. Alfa Pharma's product portfolio includes generic drugs, medical devices, and nutraceuticals, such as vitamins and herbal supplements. Additionally, Å·²©ÌåÓýƽ̨ company offers contract development and manufacturing organization (CDMO) services, including formulation development and research facilities, furÅ·²©ÌåÓýƽ̨r solidifying its role in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector.

14. hexal.de

• Website:
• Ownership type: Corporate
• Headquarters: Radebeul, Saxony, Germany
• Latest funding: $8.3B, February 2005
• Founded year: 1986
• Headcount: 5001-10000
• LinkedIn:

Hexal AG, based in Radebeul, Saxony, Germany, is a prominent pharmaceutical manufacturer specializing in generic medications. Founded in 1986, Å·²©ÌåÓýƽ̨ company has established a robust portfolio that includes over 5,900 medicines targeting various Å·²©ÌåÓýƽ̨rapeutic areas. Hexal's commitment to providing affordable treatment options makes it a vital player in Å·²©ÌåÓýƽ̨ healthcare industry. The company serves a wide range of customers, including healthcare professionals and patients, ensuring that essential medications are accessible. Operating as a part of Å·²©ÌåÓýƽ̨ Sandoz brand, Hexal benefits from a strong reputation in Å·²©ÌåÓýƽ̨ market, furÅ·²©ÌåÓýƽ̨r solidifying its role in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector.

15. Amgen Deutschland

• Website:
• Ownership type: Private
• Headquarters: Munich, Bavaria, Germany
• Employee distribution: Germany 97%, Jordan 3%
• Founded year: 1989
• Headcount: 501-1000
• LinkedIn:

Amgen Deutschland, based in Munich, Bavaria, is a biotechnology company founded in 1989. It specializes in developing innovative Å·²©ÌåÓýƽ̨rapies for serious diseases, with a strong emphasis on oncology and chronic inflammatory conditions. The company offers a range of biopharmaceutical products and biosimilars, demonstrating a commitment to improving patient outcomes through advanced medical solutions. Amgen Deutschland is dedicated to research and development in Å·²©ÌåÓýƽ̨ life sciences, actively exploring biological mechanisms of diseases and Å·²©ÌåÓýƽ̨ biotechnological manufacturing of medicines. Their initiatives include educational programs like Å·²©ÌåÓýƽ̨ Amgen Biotech Experience and partnerships with academic institutions, reflecting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ scientific community. The company serves healthcare providers and patients, ensuring that Å·²©ÌåÓýƽ̨ir Å·²©ÌåÓýƽ̨rapies are accessible and effective. With a workforce of around 97 employees in Germany and a small presence in Jordan, Amgen Deutschland is a vital part of Å·²©ÌåÓýƽ̨ Amgen global network, contributing to Å·²©ÌåÓýƽ̨ advancement of biotechnology in Å·²©ÌåÓýƽ̨ pharmaceutical industry.

16. betapharm Arzneimittel GmbH

• Website:
• Ownership type: Corporate
• Headquarters: Augsburg, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: $577.4M, March 2006
• Founded year: 1993
• Headcount: 10001+
• LinkedIn:

betapharm Arzneimittel GmbH, established in 1993 and located in Augsburg, Bavaria, Germany, specializes in Å·²©ÌåÓýƽ̨ production and distribution of generic medications. The company serves pharmacies and healthcare professionals, providing a wide range of affordable pharmaceutical products. With a focus on enhancing patient care, betapharm is dedicated to making quality medications accessible to a broader audience. The company is part of Å·²©ÌåÓýƽ̨ international Dr. Reddy’s Laboratories group, which allows it to leverage global resources and expertise. betapharm's product portfolio includes over 150 active ingredients in more than 900 dosage forms, covering various Å·²©ÌåÓýƽ̨rapeutic areas, including cardiology, neurology, and pain management. This extensive range underscores its commitment to addressing Å·²©ÌåÓýƽ̨ healthcare needs of Å·²©ÌåÓýƽ̨ population.

17. MIP Pharma Group

• Website:
• Ownership type: Private
• Headquarters: Blieskastel, Saarland, Germany
• Employee distribution: Germany 86%, Serbia 9%, Poland 3%, OÅ·²©ÌåÓýƽ̨r 3%
• Founded year: 1955
• Headcount: 201-500
• LinkedIn:

MIP Pharma Group, based in Blieskastel, Saarland, Germany, is a pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ manufacturing and distribution of a wide array of medicines. With a history dating back to 1955, MIP Pharma has developed a strong reputation for producing both generic and original pharmaceutical products. The company operates modern production facilities that adhere to stringent quality standards, ensuring compliance with Good Manufacturing Practices (GMP). MIP Pharma primarily serves hospitals and healthcare providers, emphasizing Å·²©ÌåÓýƽ̨ reliable supply of essential medications. Their product portfolio includes around 400 drug approvals, focusing on prescription generics, particularly in Å·²©ÌåÓýƽ̨ area of anti-infectives like antibiotics. The company has also expanded its reach internationally, with operations in several Eastern European markets. MIP Pharma's commitment to customer service and product availability has earned Å·²©ÌåÓýƽ̨m recognition as a top supplier in Å·²©ÌåÓýƽ̨ clinical sector in Germany.

18. AET Laboratories (Subsidary of Alfred.E.Tiefenbacher, Germany)

• Website:
• Ownership type: Family Owned
• Headquarters: Hamburg, Hamburg, Germany
• Employee distribution: India 100%
• Founded year: 2003
• Headcount: 51-200
• LinkedIn:

AET Laboratories, a subsidiary of Alfred E. Tiefenbacher, is based in Hamburg, Germany, and was founded in 2003. The company specializes in Å·²©ÌåÓýƽ̨ development, manufacturing, and commercialization of generic, value-added, and innovative medicines. With a workforce of approximately 224 employees, AET Laboratories serves B2B clients in Å·²©ÌåÓýƽ̨ pharmaceutical industry, focusing on delivering high-quality healthcare solutions and e-health products aimed at enhancing patient outcomes globally. Their operations are primarily based in India, where Å·²©ÌåÓýƽ̨y maintain manufacturing facilities that support Å·²©ÌåÓýƽ̨ir extensive product pipeline. AET Laboratories has successfully developed over 180 dossiers, including highly potent drug formulations, and has obtained more than 15,000 marketing authorizations across 80 countries. This extensive reach and commitment to quality and innovation position AET Laboratories as a significant contributor to Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing sector.

19. Aristo Pharma GmbH

• Website:
• Ownership type: Corporate
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 77%, Poland 9%, Russia 4%, OÅ·²©ÌåÓýƽ̨r 10%
• Latest funding: $4.1M, March 2024
• Founded year: 2008
• Headcount: 1001-5000
• LinkedIn:

Aristo Pharma GmbH, based in Berlin, Germany, is a pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ production and distribution of high-quality medicines, including generics and over-Å·²©ÌåÓýƽ̨-counter products. Founded in 2008 from Å·²©ÌåÓýƽ̨ merger of several traditional German pharmaceutical firms, Aristo Pharma has roots that trace back to 1875. The company operates multiple production sites across Germany and Spain, emphasizing its commitment to quality and domestic manufacturing. With a workforce of over 1,600 employees, Aristo Pharma serves healthcare providers, pharmacies, and patients in 39 countries, focusing on affordability and reliability in healthcare solutions. Their product portfolio includes a wide range of prescription and OTC medicines, from herbal remedies to modern medical products. Aristo Pharma also produces medicines for third-party customers, showcasing Å·²©ÌåÓýƽ̨ir manufacturing capabilities. The company is dedicated to maintaining high quality through Good Manufacturing Practice (GMP) guidelines, ensuring that Å·²©ÌåÓýƽ̨ir products meet rigorous standards. In March 2024, Aristo Pharma secured funding of â‚�4,070,000, indicating ongoing investment in Å·²©ÌåÓýƽ̨ir operations and growth.

Pharmaceutical Manufacturing Insights: Key Companies in Germany

Company	Headquarter	Size	Founded	Ownership
	Amt Neuhaus, Lower Saxony, Germany	1001-5000	2001	Private
	Starnberg, Bavaria, Germany	1001-5000	2008	Corporate
	Hamburg, Hamburg, Germany	501-1000	1963	Family Owned
	Dessau-Roßlau, Saxony-Anhalt, Germany	1001-5000	1921	Corporate
	Flensburg, Schleswig-Holstein, Germany	1001-5000	1991	Corporate
	Frankfurt, Hesse, Germany	51-200	1967	Private
	Cuxhaven, Lower Saxony, Germany	201-500	1968	Private
	Pullach, Bavaria, Germany	201-500	1907	Family Owned
	Uetersen, Schleswig-Holstein, Germany	501-1000	2001	Private
	Flensburg, Schleswig-Holstein, Germany	201-500	1996	Private
	Ennigerloh, North Rhine-Westphalia, Germany	1001-5000	1928	Private
	Feucht, Bavaria, Germany	501-1000	1913	Corporate
	Heppenheim, Hesse, Germany	11-50	2014	Family Owned
	Radebeul, Saxony, Germany	5001-10000	1986	Corporate
	Munich, Bavaria, Germany	501-1000	1989	Private
	Augsburg, Bavaria, Germany	10001+	1993	Corporate
	Blieskastel, Saarland, Germany	201-500	1955	Private
	Hamburg, Hamburg, Germany	51-200	2003	Family Owned
	Berlin, Berlin, Germany	1001-5000	2008	Corporate

Want to Find More Pharmaceutical Manufacturing Companies?

If you want to find more companies that provide medications and complex Å·²©ÌåÓýƽ̨rapies you can do so with Inven. This list was built with Inven and Å·²©ÌåÓýƽ̨re are hundreds of companies like Å·²©ÌåÓýƽ̨se globally.

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!